Pharmacokinetic-Pharmacodynamic Disease Progression Model for Effect of Etanercept in Lewis Rats with Collagen-Induced Arthritis

The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells

(2010) M. SHINGU et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Therapeutic options for rheumatoid arthritis

(2009) Michael G Feely et al.   EXPERT OPINION ON PHARMACOTHERAPY

Rheumatoid arthritis

(2009) Lars Klareskog et al.   LANCET

Effect of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, on Neuropathic Pain in the Rat Chronic Constriction Injury Model

(2009) John M. Zanella et al.   SPINE

Modeling Corticosteroid Effects in a Rat Model of Rheumatoid Arthritis I: Mechanistic Disease Progression Model for the Time Course of Collagen-Induced Arthritis in Lewis Rats

(2008) J. C. Earp et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Modeling Corticosteroid Effects in a Rat Model of Rheumatoid Arthritis II: Mechanistic Pharmacodynamic Model for Dexamethasone Effects in Lewis Rats with Collagen-Induced Arthritis

(2008) J. C. Earp et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Quantitative Dynamic Models of Arthritis Progression in the Rat

(2008) Justin C. Earp et al.   PHARMACEUTICAL RESEARCH

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

(2007) Daniel Tracey et al.   PHARMACOLOGY & THERAPEUTICS